PMID- 23141853 OWN - NLM STAT- MEDLINE DCOM- 20130823 LR - 20211021 IS - 1532-8414 (Electronic) IS - 1071-9164 (Print) IS - 1071-9164 (Linking) VI - 18 IP - 11 DP - 2012 Nov TI - Heart failure in post-MI patients with persistent IRA occlusion: prevalence, risk factors, and the long-term effect of PCI in the Occluded Artery Trial (OAT). PG - 813-21 LID - S1071-9164(12)01289-4 [pii] LID - 10.1016/j.cardfail.2012.10.012 [doi] AB - BACKGROUND: The incidence and predictors of heart failure (HF) after myocardial infarction (MI) with modern post-MI treatment have not been well characterized. METHODS AND RESULTS: A total of 2,201 stable patients with persistent infarct-related artery occlusion >24 hours after MI with left ventricular ejection fraction <50% and/or proximal coronary artery occlusion were randomized to percutaneous intervention plus optimal medical therapy (PCI) or optimal medical therapy (MED) alone. Centrally adjudicated HF hospitalizations for New York Heart Association (NYHA) III/IV HF and mortality were determined in patients with and without baseline HF, defined as a history of HF, Killip Class >I at index MI, rales, S3 gallop, NYHA II at randomization, or NYHA >I before index MI. Long-term follow-up data were used to determine 7-year life-table estimated event rates and hazard ratios. There were 150 adjudicated HF hospitalizations during a mean follow-up of 6 years with no difference between the randomized groups (7.4% PCI vs. 7.5% MED, P = .97). Adjudicated HF hospitalization was associated with subsequent death (44.0% vs. 13.1%, HR 3.31, 99% CI 2.21-4.92, P < .001). Baseline HF (present in 32% of patients) increased the risk of adjudicated HF hospitalization (13.6% vs. 4.7%, HR 3.43, 99% CI 2.23-5.26, P < .001) and death (24.7% vs. 10.8%, HR 2.31, 99% CI 1.71-3.10, P < .001). CONCLUSIONS: In the overall Occluded Artery Trial (OAT) population, adjudicated HF hospitalizations occurred in 7.5% of subjects and were associated with increased risk of subsequent death. Baseline or prior HF was common in the OAT population and was associated with increased risk of hospitalization and death. CI - Copyright (c) 2012 Elsevier Inc. All rights reserved. FAU - Jhaveri, Rahul R AU - Jhaveri RR AD - Cardiovascular Clinical Research Center, Leon Charney Division of Cardiology, New York University School of Medicine, New York, NY 10016, USA. FAU - Reynolds, Harmony R AU - Reynolds HR FAU - Katz, Stuart D AU - Katz SD FAU - Jeger, Raban AU - Jeger R FAU - Zinka, Elzbieta AU - Zinka E FAU - Forman, Sandra A AU - Forman SA FAU - Lamas, Gervasio A AU - Lamas GA FAU - Hochman, Judith S AU - Hochman JS LA - eng SI - ClinicalTrials.gov/NCT00004562 GR - U01 HL062509/HL/NHLBI NIH HHS/United States GR - U01 HL062511/HL/NHLBI NIH HHS/United States PT - Journal Article PT - Multicenter Study PT - Randomized Controlled Trial PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't PL - United States TA - J Card Fail JT - Journal of cardiac failure JID - 9442138 SB - IM MH - Aged MH - Coronary Occlusion/complications/*epidemiology/therapy MH - Female MH - Follow-Up Studies MH - Heart Failure/complications/*epidemiology/therapy MH - Humans MH - Male MH - Middle Aged MH - Myocardial Infarction/complications/*epidemiology/therapy MH - *Percutaneous Coronary Intervention/trends MH - Prevalence MH - Risk Factors MH - Time Factors MH - Treatment Outcome PMC - PMC3518044 MID - NIHMS417171 EDAT- 2012/11/13 06:00 MHDA- 2013/08/24 06:00 PMCR- 2013/11/01 CRDT- 2012/11/13 06:00 PHST- 2012/04/17 00:00 [received] PHST- 2012/10/05 00:00 [revised] PHST- 2012/10/05 00:00 [accepted] PHST- 2012/11/13 06:00 [entrez] PHST- 2012/11/13 06:00 [pubmed] PHST- 2013/08/24 06:00 [medline] PHST- 2013/11/01 00:00 [pmc-release] AID - S1071-9164(12)01289-4 [pii] AID - 10.1016/j.cardfail.2012.10.012 [doi] PST - ppublish SO - J Card Fail. 2012 Nov;18(11):813-21. doi: 10.1016/j.cardfail.2012.10.012.